Table of Contents
In 2022, the hemp industry’s future was supposed to be CBD and Delta-8 growth “without limits.” By late 2026, the picture is very different. Congress passed P.L. 119-37: on November 12, 2026, cannabinoids the plant cannot naturally produce (THC-O and similar) lost hemp status; on December 11, 2026, the total-THC test (including THCA), a 0.4 mg-per-container cap, and the exclusion of converted and synthesized cannabinoids took effect — ending the legal basis for converted Delta-8. The FDA never got the CBD regulatory pathway it asked Congress for in January 2023, and CBD remains barred from food and supplements in interstate commerce. States filled the gap with their own bans, caps, and licensing regimes. The “therapeutic effects” claims of 2022 remain largely unproven — the only FDA-approved CBD product is still Epidiolex, for three seizure conditions. The NCCIH cannabis evidence summary is the frame for all health claims on this site.
2022 predictions vs 2026 reality
| 2022 prediction | Late 2026 reality |
|---|---|
| Endless Delta-8 growth | Converted cannabinoids excluded by P.L. 119-37 |
| CBD regulatory clarity coming | No pathway enacted; FDA bars CBD in food/supplements |
| Therapeutic mainstreaming | Only Epidiolex proven; other claims unproven |
| Uniform federal framework | State-by-state patchwork of bans, caps, licenses |
Businesses that survived adapted to compliance, not growth projections. The FDA’s CBD regulatory position explains the federal framework. See our FDA and CBD guide and our Delta-8 THC: what you need to know.
Related
See our wholesale CBD gummies guide and our CBD statistics guide.
Frequently asked questions
What happened to Delta-8?
P.L. 119-37 excluded converted and synthesized cannabinoids from the hemp definition.
Is CBD federally legal?
Hemp-derived CBD under 0.3% THC is permitted, but CBD in food/supplements is barred in interstate commerce.
Did the FDA create a CBD pathway?
No — the agency asked Congress in January 2023; no pathway was enacted as of late 2026.
Is the hemp industry still growing?
The market exists but is reshaped by regulation; no reliable growth figures exist.
What is the only FDA-approved CBD product?
Epidiolex, approved June 25, 2018, for seizures in three conditions.
Browse the CBD Guides hub.
Affiliate Disclosure
The CakeHeights Editorial Team is committed to providing accurate, research-backed information about cannabis and hemp products. Some links on this page are affiliate links, meaning we may earn a commission at no extra cost to you if you make a purchase through them. Our recommendations are based on independent research, testing, and analysis. We only promote products we believe offer genuine value to our readers. Learn more →